LENZ Therapeutics, Inc. (LENZ)
14.68
+1.19
(+8.82%)
USD |
NASDAQ |
Mar 02, 13:24
LENZ Therapeutics EPS Diluted (Quarterly) : -0.5851 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CDT Equity, Inc. | -13.16 |
| Liminatus Pharma, Inc. | -0.0675 |
| Oruka Therapeutics, Inc. | -0.6871 |
| Maze Therapeutics, Inc. | -0.6258 |
| MapLight Therapeutics, Inc. | -0.6484 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.70M |
| Revenue (Quarterly) | 12.50M |
| Total Expenses (Quarterly) | 29.20M |
| Enterprise Value | 220.88M |
| Gross Profit Margin (Quarterly) | 99.00% |
| Profit Margin (Quarterly) | -133.6% |
| Earnings Yield | -14.36% |
| Normalized Earnings Yield | -14.36 |